Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A control labeled, double arm, comparative, multicentric, prospective, Phase III trial to compare the safety and efficacy of fixed dose combination of Cefpodoxime 200mg and Dicloxacillin 500mg with Cefpodoxime 200mg in subjects suffering with various bacterial respiratory tract infections.

Next Previous
Trial Profile

A control labeled, double arm, comparative, multicentric, prospective, Phase III trial to compare the safety and efficacy of fixed dose combination of Cefpodoxime 200mg and Dicloxacillin 500mg with Cefpodoxime 200mg in subjects suffering with various bacterial respiratory tract infections.

Status: Recruiting
Phase of Trial: Phase III

Latest Information Update: 13 Apr 2013

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cefpodoxime; Cefpodoxime/dicloxacillin
  • Indications Bacterial infections; Respiratory tract infections
  • Focus Therapeutic Use
  • Sponsors Theon Pharmaceuticals

Most Recent Events

  • 22 Jul 2010 New trial record

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top